Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Transcenta to Present Three Study Results at ESMO 2023 2023-08-16 08:00
Inmagene's OX40 mAb, with an extended half-life and silenced ADCC, enters POC study in Atopic Dermatitis 2023-08-15 22:50
CStone Pharmaceuticals Reports 2023 Interim Results and Updates 2023-08-15 22:33
Everest Medicines' Partner Venatorx Receives FDA Acceptance and Priority Review of New Drug Application for Cefepime-Taniborbactam to Treat Complicated Urinary Tract Infections (cUTI) 2023-08-15 20:19
OnCusp Therapeutics Receives FDA Clearance for the Phase 1 Clinical Trial of CUSP06, Targeting Ovarian Cancer and Other Advanced Solid Tumors 2023-08-15 20:00
TB Alliance Announces Partnership with Remington Pharmaceuticals to Commercialize New Therapy for Drug-Resistant Forms of TB in Pakistan 2023-08-14 21:30
Kelun-Biotech announces that a Phase III clinical trial of core product SKB264 (MK-2870, TROP2-ADC) in patients with unresectable locally advanced, recurrent or metastatic TNBC who have failed second-line or above prior standard of care has met its primary endpoint 2023-08-14 12:50
Streamlining Generic Drug Immunogenicity Evaluation: EpiVax's "PANDA" Approach 2023-08-11 21:14
Asieris Announces Positive Phase III Bridging Trial of Hexvix®, a Diagnostic Drug for Bladder Cancer 2023-08-11 17:00
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients 2023-08-11 11:14
WuXi XDC and Boostimmune Sign MOU for Integrated Services 2023-08-11 08:30
Antengene Enters into Commercialization Partnership with Hansoh Pharma for First/Only-in-Class XPO1 Inhibitor XPOVIO®(selinexor) in the Mainland of China 2023-08-11 08:00
First Patient Dosed in Pivotal Phase III Study of TLX591-CDx (Illuccix®) for Prostate Cancer Imaging in Chinese Patients 2023-08-11 07:18
YS Biopharma to Report First Quarter Fiscal Year 2024 Financial Results on August 15, 2023 2023-08-11 04:30
Standigm and Nashville Biosciences join to revolutionize early drug discovery 2023-08-10 21:07
Oricell OriCAR-017 CAR-T Therapy Clears IND Hurdle, Paving the Way for Global Impact 2023-08-10 21:00
AffaMed Therapeutics Announces Partner Vistagen Reports Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder 2023-08-10 15:49
Pfizer's Pneumococcal 20-Valent Conjugate Vaccine is Now Available in Hong Kong, For Adults Aged 18 Years or Older[1] 2023-08-10 14:15
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan 2023-08-09 13:00
Everest Medicines to Announce First Half 2023 Financial Results on August 24, 2023 2023-08-09 08:06
1 86 87 88 89 90 413